1Behrens R J, Levi AW, Westra WH, et al. Langerhans cell histiocyosis of the throid : a report of two cases and review of the literature. Thyroid,2001,11:697-705.
2Yap WM, Chuah KL, Tan PH. Langerhans call histiocyosis involving the thyroid and parathyroid glands. Mod Pathol,2001, 14:111-115.
4Munn S, Chu AC. Langerhans ell histiocytosis of ther skin. Hamatol Oncol Clin North AM, 1998,12:269-286.
5Broadbent V, Pritchard J, Yeomans E. Etoposide ( VPI6 ) in the treatment of multisystem langerhans cell histiocytosis (histiocytosisX). Med Pediatr Oncol, 1989,17:97.
6Thomas SL, Ducre B, Aecchi T, et al. Successful tretment of adult's Langerhans cell histiocytosis with Thalidomide: report of two cases and literature review. Arch Dermatol, 1993,129 : 1261- 1264.
7Rowland TL, McHugh SM, Deighton J, et al. Differential regulation by thalidomide and dexamethasone of cytoline expression in human peripheral blood mononuclear cells. Immunoharmacology, 2002, 43:401-406.
8Klausner JD, Freedman VH, Kaplan G. Thalidomide as an anti- TNF-α inhibitor, implications for clinical use. Clin Immunol Immunopathol, 1996,81:219-223.
9Turk BE,Jiang H,Liu JO,et al. Binding of thalidomide to α1 acid glycoprotein may be involved in is inhibiton of Tumor necrosis factor-α production. Proc Natl Acad Sci USA, 1996,93: 7552- 7556.
